4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000905718-17-000636
Director sold 81,435 shares at an average $17.08 ($1,390,611)
From the SEC's structured data for this filing
Trades in this filing
EMSTER KURT VON · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-06-26 | Sale : show line 1 in the form | −48,001 | $16.83 | $807,857 | 2,521,445 | I |
| 2017-06-27 | Sale : show line 2 in the form | −33,434 | $17.43 | $582,755 | 2,488,011 | I |
| Open-market sales · 81,435 sh · avg $17.08 · $1,390,611 | ||||||
Loading xslF345X03/vonemster_form4jun262017.xml…